Abstract Short Summary
Abstract
Objective:
To evaluate the revision surgery rates and device survival of the Rigicon Infla10 inflatable penile prosthesis in a global cohort.
Key Findings:
Among 535 patients, only 3.5% required revision, mainly for mechanical failure (2.24%). The 3-year revision-free survival rate was 94%, comparable to competitor IPPs. Mechanical failures were primarily due to reservoir tubing leakage.
Conclusion:
The Rigicon Infla10 demonstrates high device survival and low revision rates, aligning with those of established devices, affirming its safety and durability.
Clinical Relevance:
The findings support Rigicon Infla10 as a reliable and safe option for ED patients, reassuring clinicians about its revision-free durability over a 3-year period.
Keywords
This publication is available through the external link above. See the abstract for a summary of the research.